In addition, NR3B1 activates transcription of the genes contained in the ERBB2 amplicon observed in the majority of HER2+ breast tumors, possibly explaining the delay in tumor development observed following NR3b1 knock-out in a mouse model of ERBB2-initiated mammary cancerogenesis [89]. This evidence concerns the gene ERBB2 and neoplasm.